Jay Feingold is Chief Medical Officer of Pyxis Oncology, Inc.. Currently has a direct ownership of 730,345 shares of PYXS, which is worth approximately $2.1 Million. The most recent transaction as insider was on Mar 24, 2023, when has been sold 209,803 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 730K
0% 3M change
0% 12M change
Total Value Held $2.1 Million

Jay Feingold Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 24 2023
BUY
Grant, award, or other acquisition
-
209,803 Added 22.32%
730,345 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
53,931 Added 9.39%
520,542 Common Stock
Apr 14 2022
BUY
Grant, award, or other acquisition
-
115,931 Added 19.9%
466,611 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
306,930 Added 46.67%
350,680 Common Stock
Oct 07 2021
BUY
Grant, award, or other acquisition
-
43,750 Added 50.0%
43,750 Common Stock
JF

Jay Feingold

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on PYXS

Follow Pyxis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PYXS shares.

Notify only if

Insider Trading

Get notified when an Pyxis Oncology, Inc. insider buys or sells PYXS shares.

Notify only if

News

Receive news related to Pyxis Oncology, Inc.

Track Activities on PYXS